ScholarIQanswers from OpenAlex

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis

PaperCitations, authors & open-access status

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis have?

ScholarIQcitation count

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis has 56 citations in the OpenAlex counts ScholarIQ stores.

When was Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis published?

ScholarIQyear

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis has 2004 year in the ScholarIQ index.

What is the open-access status of Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis?

ScholarIQoa status

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis has closed oa status in the ScholarIQ index.

What is the DOI of Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis?

ScholarIQdoi

The DOI for Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis is on the source record.

What is the PMID of Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis?

ScholarIQpmid

The PMID for Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis is on the source record.

What is the OpenAlex record for Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis?

ScholarIQopenalex

The OpenAlex for Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial